Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
602 hedge funds and large institutions have $15.1B invested in Exact Sciences in 2021 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 247 increasing their positions, 171 reducing their positions, and 70 closing their positions.
44% more repeat investments, than reductions
Existing positions increased: 247 | Existing positions reduced: 171
1.97% more ownership
Funds ownership: 90.04% → 92% (+2%)
3% less funds holding
Funds holding: 623 → 602 (-21)
20% less first-time investments, than exits
New positions opened: 56 | Existing positions closed: 70
21% less capital invested
Capital invested by funds: $19.2B → $15.1B (-$4.1B)
32% less call options, than puts
Call options by funds: $170M | Put options by funds: $250M
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$327M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$106M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
+$101M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$98.9M |
| 5 |
SCM
Spyglass Capital Management
San Francisco,
California
|
+$63.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$136M |
| 2 |
JP Morgan Chase
New York
|
-$102M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$93.5M |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$60.6M |
| 5 |
Morgan Stanley
New York
|
-$48.7M |
EXAS Hedge Fund Activity: Q3 2021 in Review
602 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2021, worth a combined $15.1B — down 21% from $19.2B a quarter earlier.
Sellers outnumbered buyers: 70 funds closed out of EXAS and 56 opened new positions — a net loss of 14 holders — while 171 trimmed existing stakes and 247 added.
The largest buyer was Wellington Management Group, adding an estimated $327M. The largest seller was T. Rowe Price Associates, cutting an estimated $136M.
- 602 institutional investors held Exact Sciences (EXAS) as of Q3 2021, down from 623 in Q2 2021.
- Funds reported $15.1B of Exact Sciences stock for Q3 2021, down 21% quarter-over-quarter.
- 56 funds opened new Exact Sciences positions in Q3 2021 and 70 closed out, a net change of -14 holders.
- The largest Exact Sciences buyer in Q3 2021 was Wellington Management Group, an estimated $327M added.
- The largest Exact Sciences seller in Q3 2021 was T. Rowe Price Associates, an estimated $136M sold.
Based on aggregated 13F filings for Q3 2021.